The DOI matches its Crossref record.
Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
Abstract
Potentially fatal physiologic and metabolic derangements can occur in response to bacterial infection in animals and man. Recently it has been shown that alterations in the levels of circulating cytokines such as IL-6 and TNF-alpha occur shortly after bacterial challenge. To understand better the role of IL-6 in inflammation, we investigated the effects of in vivo anti-mouse IL-6 antibody treatment in a mouse model of septic shock. Rat anti-mouse IL-6 neutralizing mAb was produced from splenocytes of an animal immunized with mouse rIL-6. This mAb, MP5-20F3, was a very potent and specific antagonist of mouse IL-6 in vitro bioactivity, demonstrated using the NFS60 myelomonocytic and KD83 plasmacytoma target cell lines, and also immunoprecipitated radiolabeled IL-6. Anti-IL-6 mAb pretreatment of mice subsequently challenged with lethal doses of i.p. Escherichia coli or i.v. TNF-alpha protected mice from death caused by these treatments. Pretreatment of E. coli-challenged mice with anti-IL-6 led to an increase in serum TNF bioactivity, in comparison to isotype control antibody, implicating IL-6 as a negative modulator of TNF in vivo. Anti-TNF-alpha treatment of mice challenged i.p. with live E. coli resulted in a 70% decrease in serum IL-6 levels, determined by immunoenzymetric assay, compared to control antibody, thereby supporting a role for TNF-alpha as a positive regulator of IL-6 levels. We conclude that IL-6 is a mediator in lethal E. coli infection, and suggest that antagonists of IL-6 may be beneficial therapeutically in life-threatening bacterial infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents
Sampson, H. A., Mendelson, L., & Rosen, J. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208063270603 · Cited by 1,609
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Self-citationInterleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
Fiers, W. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80803-b · Cited by 694
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 658
Biological properties of interleukin 10
Howard, M., & O'Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 640
Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1529 · Cited by 517
Interleukin-6 in the Injured Patient: Marker of Injury or Mediator of Inflammation?
Biffl, W. L., Moore, E. E., Moore, F. A., & Peterson, V. M. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00009 · Cited by 502
The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients
Fingerle, G., Pforte, A., Passlick, B., Blumenstein, M., Strobel, M., & Ziegler- Heitbrock, H. (1993) · Blood · doi:10.1182/blood.v82.10.3170.3170 · Cited by 497
Wysocka, M., Kubin, M., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P., & Trinchieri, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250307 · Cited by 467
Roake, J. A., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F., & Austyn, J. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2237 · Cited by 464
Systemic inflammatory response syndrome
Davies, M. G., & Hagen, P.-O. (1997) · Journal of British Surgery · doi:10.1002/bjs.1800840707 · Cited by 456
Bellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 430
The systemic inflammatory response syndrome
Meeran, H., & Messent, M. (2001) · Trauma · doi:10.1177/146040860100300203 · Cited by 425
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 418
Guidotti, L. G., Ando, K., Hobbs, M. V., Ishikawa, T., Runkel, L., Schreiber, R. D., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3764 · Cited by 412
Interleukin-11: a new cytokine critical for osteoclast development.
Girasole, G., Passeri, G., Jilka, R. L., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117130 · Cited by 399
Zhang, Y., Chirmule, N., Gao, G.-P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0329 · Cited by 376
Hunter, C. A., Subauste, C. S., Van Cleave, V. H., & Remington, J. S. (1994) · Infection and Immunity · doi:10.1128/iai.62.7.2818-2824.1994 · Cited by 362
Biological properties of interleukin 10
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918147 · Cited by 348
Zellweger, R. M., Prestwood, T. R., & Shresta, S. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.004 · Cited by 338
Fischer, E., Marano, M. A., Van Zee, K. J., Rock, C. S., Hawes, A. S., Thompson, W. A., DeForge, L., Kenney, J. S., Remick, D. G., & Bloedow, D. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115748 · Cited by 333
Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Interleukin-8 in sepsis: relation to shock and inflammatory mediators
Hack, C. E., Hart, M., van Schijndel, R. J., Eerenberg, A. J., Nuijens, J. H., Thijs, L. G., & Aarden, L. A. (1992) · Infection and Immunity · doi:10.1128/iai.60.7.2835-2842.1992 · Cited by 319
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F., & Poli, V (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1345 · Cited by 313
Matmati, M., Jacques, P., Maelfait, J., Verheugen, E., Kool, M., Sze, M., Geboes, L., Louagie, E., Guire, C. M., Vereecke, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.874 · Cited by 290
Dalrymple, S. A., Lucian, L. A., Slattery, R., McNeil, T., Aud, D. M., Fuchino, S., Lee, F., & Murray, R. (1995) · Infection and Immunity · doi:10.1128/iai.63.6.2262-2268.1995 · Cited by 287
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Tilders, F. J. H., DeRuk, R. H., Van Dam, A.-M., Vincent, V. A. M., Schotanus, K., & Persoons, J. H. A. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90010-8 · Cited by 277
IL-6: Insights into Novel Biological Activities
Barton, B. E. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4420 · Cited by 269
Role of the neutrophil in adult respiratory distress syndrome
Windsor, A. C. J., Mullen, P. G., Fowler, A. A., & Sugerman, H. J. (1993) · Journal of British Surgery · doi:10.1002/bjs.1800800106 · Cited by 259
Perlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., & Neta, R. (1993) · Endocrinology · doi:10.1210/en.132.3.946 · Cited by 257
Self-citationIL-6 stimulates intestinal epithelial proliferation and repair after injury
Kuhn, K. A., Manieri, N. A., Liu, T.-C., & Stappenbeck, T. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114195 · Cited by 254
Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6
Oldenburg, H. S. A., Rogy, M. A., Lazarus, D. D., van Zee, K. J., Keeler, B. P., Chizzonite, R. A., Lowry, S. F., & Moldawer, L. L. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230824 · Cited by 155
Matthys, P., Mitera, T., Heremans, H., Van Damme, J., & Billiau, A. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1158-1164.1995 · Cited by 134
Metadata
- Authors
- Starnes, H. F., Pearce, M. K., Tewari, A., Yim, J. H., Zou, J. C., & Abrams, J. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-12
- Volume
- 145
- Issue
- 12
- Pages
- 4185-4191
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1658552097
- Cited by
- 322
- References
- 0
- FWCI
- 18.85
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.